OCAC was formed with the aim of identifying genes/alleles related to the risk of ovarian cancer. We have broadened the scope to include identification of germline genetic variation associated with clinical phenotypes such as overall survival and tumour sub-type. In addition there are associated studies of chemo-responsiveness.

• SNPs for ovarian cancer risk - contact: Dr Andy Berchuck
• SNPs for overall survival – contact: Dr Andy Berchuck
• SNPs for chemoresponsiveness – contact: Dr Georgia Chenevix-Trench
• Pathology of ovarian cancer – contact: Dr Susan Ramus